The UAE has become the second country to approve once-daily, oral pill - Lipfendra - to treat adults with elevated low-density lipoprotein (LDL-C) cholesterol, a leading risk factor for cardiovascular disease.
Making the announcement, the Emirates Drug Establishment (EDE) explained that Lipfendra can also treat "certain inherited conditions" as long as it is cleared by a healthcare professional.
It is said to expand treatment options for adults and improve their quality of life.
Patients are advised to maintain a balanced diet and regular physical activity alongside the treatment.
The move is part of efforts by the UAE to authorise innovative medicines and expand treatment options for adults.
UAE allocates $8 million to support Chad amid El Nino food crisis
UAE, Syrian Presidents discuss stronger economic and development ties
H.H. Sheikh Mohammed reaffirms 'relations with Syria' during meeting with Al-Sharaa
Abu Dhabi streamlines holiday home regulatory process
